SARA CARIAN focuses on all aspects of mergers and acquisitions, including stock and asset acquisitions and divestitures, complex carve-out transactions, cross-border transactions and joint ventures. Sara represents strategic and private equity buyers and sellers and public and private companies.
Experience
Representative Matters
Notable transactions include representing the following:
The Nemetschek Group in its acquisition of Firmus AI through its subsidiary Bluebeam, Inc.
Salesforce in its acquisition of Vlocity, Inc. for US$1.33 billion and its acquisition of CloudCraze.
Armis, a leading asset intelligence cybersecurity company, in its acquisition of Silk Security.
Quest in its acquisitions of Binary Tree, a leading provider of cloud migration and modernization solutions for Microsoft Platforms, Quadrotech, a leading provider of Microsoft 365 and Office 365 migration and management, and erwin, Inc., a provider of data modeling, metadata management and data intelligence and business process modeling products.
WatchGuard Technologies, a global leader in network security and intelligence, advanced endpoint protection, multi-factor authentication and secure Wi-Fi, in its sale to Vector Capital.
CloudSense in its sale to Skyvera.
Stackbit Inc., a developer of a website-designing technology platform, in its sale to Netlify.
Autodesk, Inc. in its acquisition of Upchain Inc.
Zingbox, Inc. in its sale to Palo Alto Networks.
Centrify Corporation in connection with a majority investment by an affiliate of Thoma Bravo.
Cadence Design Systems, Inc. in its acquisitions of nusemi inc and SFM Technology, Inc.
Brocade Communication Systems, Inc. in its sales of certain software assets.
McAfee in its acquisition of Light Point Security.
Vector Capital in its sale of Corel Corporation to KKR.
Corel Corporation in its acquisition of the Parallels business.
DaVita, Inc. in the formation of Mozarc Medical, its joint venture with Medtronic, a kidney care-focused medical device company focused on developing broad suite of novel kidney care products and solutions.
Roche in its acquisition of diagnostics company GenMark (NSDQ:GNMK) for US$1.8 billion.
Gamma Biosciences, a life sciences tools platform created by KKR, in its acquisitions of Nanopareil, a developer of nanofiber membrane products for chromatographic separation in bioproduction, and Essential Life Solutions, a provider of chromatography columns and accessories used in life science research and bioprocess development.
Acerus Pharmaceuticals in its acquisition of Serenity Pharmaceuticals, a specialty pharmaceutical company focused on developing therapies for diseases associated with voiding disorders, and the global rights to its Noctiva brand.
Varian Medical Systems in its acquisitions of Endocare, Alicon, and Boston Scientific’s microsphere and bland embolic bead business.
Volkswagen AG in its co-investment with Ford Motor Company in autonomous vehicle technology company, Argo AI, valuing Argo at US$7.1 billion.
Resident Home, Inc. in its sale to Ashley Home, Inc., an affiliate of Ashley Global Retail, LLC.
Henkels & McCoy Group Inc., a large U.S. private electrical power transmission and distribution utility services firm, in its sale to MasTec, Inc. for US$600 million.
Variant Equity in its acquisition of Coach USA Administration, Inc. from Stagecoach Group Plc.
Centerview Partners LLP as financial advisor to the Independent Transaction Committee of the Board of Directors of Sprint Corporation in connection with the proposed combination of Sprint and T-Mobile US, Inc. valued at US$146 billion.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
You have successfully set your edition to United States. Would you like to make this selection your default edition?
*Selecting a default edition will set a cookie.
This page is available in your default region.
Close
Cookies Notice
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
Analytical Cookies
Analytical cookies help us improve our website by collecting and reporting usage information. You may opt out of analytical cookies by sliding the button to the left. You may change your preference at any time by clicking on the cookies icon.